Search Results for keywords:"Rockville Maryland"

The National Cancer Institute has announced a change to the meeting dates and times for the Special Emphasis Panel on Informatics Technologies for Cancer Research. Originally scheduled for January 29, 2025, the meeting will now take place on February 6 and 7, 2025. The meeting will still be held at the National Cancer Institute in Rockville, Maryland, but it will be closed to the public. This update was officially recorded in the Federal Register on December 19, 2024.

The National Cancer Institute is holding a meeting on April 4, 2025, to review and evaluate grant applications related to cancer research in physical sciences oncology. This meeting, held virtually, will be closed to the public due to the sensitive nature of the discussions, which may disclose confidential information. The meeting's contact person is Saejeong J. Kim, Ph.D., and it will take place from 11:30 a.m. to 4:30 p.m. at the National Cancer Institute in Rockville, Maryland.

The Atomic Safety and Licensing Board has been restructured following the retirement of Administrative Judge Paul S. Ryerson on November 30, 2024. Administrative Judge G. Paul Bollwerk, III will now serve as the Presiding Officer in the ongoing legal case concerning Yucca Mountain Nevada High-Level Waste Geologic Repository. This reconstitution ensures that all legal correspondence and documents will continue to be filed through the NRC's electronic filing system as usual. This change was formalized in Rockville, Maryland, on December 3, 2024.

The Nuclear Regulatory Commission (NRC) announced its meeting schedule for the upcoming weeks, starting December 23, 2024, and extending into January 2025. No meetings are planned for most of these weeks, except on January 14, 2025, when a public meeting will be held to discuss the Strategic Programmatic Overview of the Decommissioning and Low-Level Waste and Nuclear Materials Users Business Lines. The meeting will take place in Rockville, Maryland, and can also be viewed live via webcast. The NRC provides accommodations for individuals with disabilities and offers contact information for those needing assistance or wishing to obtain electronic notices.

The National Cancer Institute has announced a change to the schedule of the Special Emphasis Panel meeting on clinical and translational cancer research. Originally scheduled to end at 7 p.m. on February 5, 2025, the meeting will now conclude earlier, at 2 p.m. The meeting, held from February 4-5, 2025, will take place at the National Cancer Institute in Rockville, Maryland, and will remain closed to the public.

The Advisory Committee on Childhood Vaccines (ACCV), part of the Health Resources and Services Administration within the Department of Health and Human Services, has announced plans for public meetings throughout 2021. These meetings will occur on four dates: March 4, June 3, September 2, and December 2, all running from 10:00 a.m. to 4:00 p.m. Eastern Time. The meetings may be held in person in Rockville, Maryland, or via teleconference and webinar, and the public is invited to participate. The ACCV advises on the National Vaccine Injury Compensation Program and related issues, and attendees are encouraged to submit comments or questions in advance.

The National Cancer Institute announced that it will hold two closed meetings in March 2025 to discuss and evaluate grant applications. The meetings will not be open to the public because they might involve discussing confidential information like trade secrets and personal data. Both meetings will be held virtually from the National Cancer Institute in Rockville, Maryland. The meetings aim to focus on different aspects of cancer research, including clinical and translational research, and biospecimen science approaches.

The National Institute of Allergy and Infectious Diseases has announced a closed meeting to review grant applications related to immunobiology of xenotransplantation. This meeting will take place from April 3-7, 2025, from 10:00 a.m. to 5:00 p.m., at the National Institutes of Health in Rockville, Maryland. The discussions will be confidential to protect trade secrets and personal information and will be conducted via video. For more details, contact James T. Snyder, Ph.D. at the National Institutes of Health.

The National Institute of Allergy and Infectious Diseases (NIAID) announced a closed meeting on January 9, 2025, for evaluating contract proposals related to diagnostics for specific diseases. The meeting will be held virtually at the NIAID offices in Rockville, Maryland. It will discuss sensitive information such as trade secrets and personal data, which is why it is not open to the public. Shilpakala Ketha, a Scientific Review Officer at NIAID, is the contact person for this meeting.

The National Institute on Deafness and Other Communication Disorders announced two closed virtual meetings to review and evaluate grant applications. These meetings will take place on April 2 and April 4, 2025, at the National Institutes of Health in Rockville, Maryland. The discussions will be private because they might reveal confidential information such as trade secrets, commercial property, or personal details that could invade privacy. The meetings are part of the Federal Advisory Committee and will be conducted under the guidance of the respective Scientific Review Officers, Dr. Kausik Ray and Dr. Andrea B. Kelly.